These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 26376676

  • 1. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H, Wang Y, Yin L, Han Y, Sun L, Wang Z, Lin Q, Bi X, Jiao Y, Jia H, Zhao J, Huang Z, Li Z, Zhou J, Song W, Meng K, Cai J.
    Oncotarget; 2015 Oct 13; 6(31):31927-43. PubMed ID: 26376676
    [Abstract] [Full Text] [Related]

  • 2. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J, Lin W, Cao Z, Liu L, Zhuang Q, Zhong X, Hong Z, Peng J.
    Oncol Rep; 2013 Sep 13; 30(3):1309-14. PubMed ID: 23828071
    [Abstract] [Full Text] [Related]

  • 3. Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.
    Zhu S, Wang Z, Li Z, Peng H, Luo Y, Deng M, Li R, Dai C, Xu Y, Liu S, Zhang G.
    Oncotarget; 2015 Apr 30; 6(12):10460-72. PubMed ID: 25865044
    [Abstract] [Full Text] [Related]

  • 4. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
    Zuo M, Li C, Lin J, Javle M.
    Oncotarget; 2015 May 10; 6(13):10940-9. PubMed ID: 25883212
    [Abstract] [Full Text] [Related]

  • 5. Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo.
    Mohan CD, Bharathkumar H, Bulusu KC, Pandey V, Rangappa S, Fuchs JE, Shanmugam MK, Dai X, Li F, Deivasigamani A, Hui KM, Kumar AP, Lobie PE, Bender A, Basappa, Sethi G, Rangappa KS.
    J Biol Chem; 2014 Dec 05; 289(49):34296-307. PubMed ID: 25320076
    [Abstract] [Full Text] [Related]

  • 6. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3.
    Subramaniam A, Shanmugam MK, Ong TH, Li F, Perumal E, Chen L, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Hui KM, Sethi G.
    Br J Pharmacol; 2013 Oct 05; 170(4):807-21. PubMed ID: 23848338
    [Abstract] [Full Text] [Related]

  • 7. Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma.
    Li S, Priceman SJ, Xin H, Zhang W, Deng J, Liu Y, Huang J, Zhu W, Chen M, Hu W, Deng X, Zhang J, Yu H, He G.
    PLoS One; 2013 Oct 05; 8(12):e81657. PubMed ID: 24324713
    [Abstract] [Full Text] [Related]

  • 8. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q, Cao P.
    Cancer Lett; 2013 Jan 28; 328(2):243-51. PubMed ID: 23032719
    [Abstract] [Full Text] [Related]

  • 9. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
    Su JC, Chiang HC, Tseng PH, Tai WT, Hsu CY, Li YS, Huang JW, Ko CH, Lin MW, Chu PY, Liu CY, Chen KF, Shiau CW.
    Carcinogenesis; 2014 Dec 28; 35(12):2807-14. PubMed ID: 25322871
    [Abstract] [Full Text] [Related]

  • 10. Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling.
    Yang JG, Lu R, Ye XJ, Zhang J, Tan YQ, Zhou G.
    Int J Mol Sci; 2017 Jan 12; 18(1):. PubMed ID: 28085115
    [Abstract] [Full Text] [Related]

  • 11. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC, Su YT, Chi CC, Kuo YC, Lee KF, Wu YC, Lan PC, Yang MH, Chang TS, Huang YH.
    J Exp Clin Cancer Res; 2019 Nov 26; 38(1):474. PubMed ID: 31771617
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells.
    Liu Y, Liu A, Li H, Li C, Lin J.
    Cancer Prev Res (Phila); 2011 Aug 26; 4(8):1296-305. PubMed ID: 21490132
    [Abstract] [Full Text] [Related]

  • 13. Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells.
    Lu PH, Chen MB, Liu YY, Wu MH, Li WT, Wei MX, Liu CY, Qin SK.
    Oncotarget; 2017 Apr 04; 8(14):22800-22810. PubMed ID: 28206952
    [Abstract] [Full Text] [Related]

  • 14. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
    Won C, Lee CS, Lee JK, Kim TJ, Lee KH, Yang YM, Kim YN, Ye SK, Chung MH.
    Anticancer Res; 2010 Feb 04; 30(2):481-8. PubMed ID: 20332458
    [Abstract] [Full Text] [Related]

  • 15. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H, Yan D, Wang Y, Shi W, Liu T, Zhao C, Huo S, Duan J, Tao J, Zhai M, Luo P, Guo J, Tian L, Mageta L, Jou D, Zhang C, Li C, Lin J, Lv J, Li S, Lin L.
    Cancer Sci; 2019 Mar 04; 110(3):950-961. PubMed ID: 30648776
    [Abstract] [Full Text] [Related]

  • 16. A pumpkin polysaccharide induces apoptosis by inhibiting the JAK2/STAT3 pathway in human hepatoma HepG2 cells.
    Shen W, Chen C, Guan Y, Song X, Jin Y, Wang J, Hu Y, Xin T, Jiang Q, Zhong L.
    Int J Biol Macromol; 2017 Nov 04; 104(Pt A):681-686. PubMed ID: 28634059
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma.
    Liu T, Ma H, Shi W, Duan J, Wang Y, Zhang C, Li C, Lin J, Li S, Lv J, Lin L.
    Int J Oncol; 2017 Aug 04; 51(2):555-562. PubMed ID: 28714512
    [Abstract] [Full Text] [Related]

  • 18. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
    Lee S, Lee M, Kim JB, Jo A, Cho EJ, Yu SJ, Lee JH, Yoon JH, Kim YJ.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):1247-1254. PubMed ID: 27091428
    [Abstract] [Full Text] [Related]

  • 19. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.
    Gu FM, Li QL, Gao Q, Jiang JH, Zhu K, Huang XY, Pan JF, Yan J, Hu JH, Wang Z, Dai Z, Fan J, Zhou J.
    Mol Cancer; 2011 Dec 15; 10():150. PubMed ID: 22171994
    [Abstract] [Full Text] [Related]

  • 20. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling.
    Huang Y, Zhou B, Luo H, Mao J, Huang Y, Zhang K, Mei C, Yan Y, Jin H, Gao J, Su Z, Pang P, Li D, Shan H.
    Theranostics; 2019 Dec 15; 9(15):4391-4408. PubMed ID: 31285768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.